First Time Loading...

FibroGen Inc
NASDAQ:FGEN

Watchlist Manager
FibroGen Inc Logo
FibroGen Inc
NASDAQ:FGEN
Watchlist
Price: 1.25 USD 0.81% Market Closed
Updated: May 18, 2024

FibroGen Inc
Other Operating Expenses

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

FibroGen Inc
Other Operating Expenses Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Other Operating Expenses Analysis
Latest Figures & CAGR of Competitors

Company Other Operating Expenses CAGR 3Y CAGR 5Y CAGR 10Y
FibroGen Inc
NASDAQ:FGEN
Other Operating Expenses
$3m
CAGR 3-Years
36%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Other Operating Expenses
$179m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Gilead Sciences Inc
NASDAQ:GILD
Other Operating Expenses
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Amgen Inc
NASDAQ:AMGN
Other Operating Expenses
-$791m
CAGR 3-Years
-52%
CAGR 5-Years
-20%
CAGR 10-Years
-7%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Other Operating Expenses
$51.6m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Other Operating Expenses
-$13.7m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is FibroGen Inc's Other Operating Expenses?
Other Operating Expenses
3m USD

Based on the financial report for Dec 31, 2023, FibroGen Inc's Other Operating Expenses amounts to 3m USD.

What is FibroGen Inc's Other Operating Expenses growth rate?
Other Operating Expenses CAGR 3Y
36%

Over the last year, the Other Operating Expenses growth was -11%. The average annual Other Operating Expenses growth rates for FibroGen Inc have been 36% over the past three years .